This page brings together practical answers on peptide dissolution, storage, solubility, purity, concentration, quality control, and peptide chemistry. For easier reading, the questions are organized by topic, and each item links to a dedicated page with a fuller answer.
References using synthetic peptides and antibodies from LifeTein: See search results on Google Scholar.
Peptide dissolution usually depends on net charge, hydrophobicity, and sequence composition. Basic peptides often dissolve better in acidic conditions, acidic peptides may respond better to basic buffers, and neutral hydrophobic peptides often require a small amount of organic solvent before dilution into water or buffer.
If a peptide remains cloudy, precipitates after dilution, or only partly dissolves, the issue is usually related to hydrophobicity, aggregation, cysteine chemistry, or mismatch between solvent and peptide charge.
Hydrophobic peptides often require staged dissolution in a strong initial solvent followed by slow dilution. Their behavior depends strongly on concentration, buffer system, and sequence pattern.
Solubility can often be estimated from charge, hydrophobic residue content, peptide length, and sequence pattern. Peptides rich in charged residues are usually easier to handle than long, neutral, hydrophobic sequences.
DMSO is often useful for hydrophobic peptides, but the final DMSO level must still be compatible with the biological system. It is usually best to dissolve the peptide in a small amount of DMSO first, then dilute slowly into the final buffer.
Disulfide-containing peptides should usually be handled under conditions that preserve the intended oxidation state. Basic buffers are not typically the first choice unless reduction is specifically intended.
Free-cysteine peptides can oxidize during handling. Degassed acidic solvents or buffers below neutral pH are often preferred to reduce uncontrolled dimerization or disulfide formation.
A¦Â peptides are highly aggregation-prone and are commonly dissolved using solvent systems such as HFIP, DMSO, aqueous ammonia, or dilute base, depending on whether the goal is monomer preparation or later fibrillation.
For long-term storage, peptides are best kept lyophilized at -20¡ëC or preferably -80¡ëC with desiccant in sealed containers. Before opening, allow the vial to equilibrate to room temperature to reduce condensation.
Aliquoting can reduce repeated freeze-thaw cycles, repeated opening of the main vial, oxidation, aggregation, and contamination risk.
Yes. Upon request, peptides can be aliquoted into smaller quantities, which can make solubility work and storage management easier.
Sealed packaging helps minimize moisture uptake and improves long-term stability before reconstitution.
The required purity depends on the application. Screening and exploratory work can tolerate lower purity than quantitative assays, in vivo studies, clinical work, or structure-based studies.
Peptide purity is the percentage of the target peptide relative to peptide-related impurities as measured by HPLC. It does not describe water, salts, or total peptide mass in the vial.
Net peptide content refers to the percentage of peptide material relative to non-peptide components such as moisture and counterions. It is different from HPLC purity.
Standard peptide QC typically includes HPLC and MS, with additional analyses such as amino acid analysis or elemental analysis available when needed.
Calculating peptide concentration requires more than just weighing the lyophilized material. Peptide content, residual moisture, salts, and sequence-specific UV absorbance all influence the real concentration.
Small peptides are often difficult to visualize by standard gel staining methods. Tricine-based SDS-PAGE and careful transfer conditions can improve resolution and detection.
Peptides are usually delivered as TFA salts, but acetate or hydrochloride forms may be preferred when residual TFA is unsuitable for the application. TFA removal often requires repeated exchange and lyophilization.
N-terminal acetylation and C-terminal amidation alter peptide charge, often reduce solubility, and may improve stability or biological relevance when the goal is to mimic the native protein more closely.
Synthetic peptides are assembled from the C-terminus to the N-terminus using solid-phase methods, typically with Fmoc or Boc chemistry to control deprotection and coupling steps.
Solid-phase synthesis attaches the growing peptide chain to a resin, enabling repeated coupling and washing cycles in an efficient, automatable process.
API peptides, catalog peptides, and custom peptides differ in intended use, production scale, standardization, and degree of customization.
The usual minimum order quantity is 1 mg, though larger scales are also supported for research and GMP peptide work.
LifeTein has synthesized very long peptides and routinely supports peptides around 50 amino acids, with more difficult sequences evaluated case by case.
Small peptides often require optimized gel systems, staining methods, and transfer conditions to be visualized clearly.
Peptide folding depends on hydrophobic interactions, hydrogen bonding, charge distribution, and in some cases disulfide bonds.
Folding occurs because the peptide chain adopts a lower-energy conformation in which hydrophobic residues are often buried and stabilizing interactions are formed.
Still looking for a specific answer? Email sales@lifetein.com or use the form above.